Skip to main content
LGND logo

LGND · Ligand Pharmaceuticals Inc

Track LGND — free
Market Cap
$5.70B
Shares
19.94M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 420
Total Value: $7,175,362,821
Total Shares: 22,712,388
Showing 1–100 of 428 holdings by value · page 1 of 5

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 420 13F filers · Δ vs Mar 31, 2026
Top Holder
13.7%
Sep 2023 → Jun 2026 · range 13.7% – 18.3%
−0.5 pts
Top 5
32.4%
Sep 2023 → Jun 2026 · range 32.3% – 48.3%
+0.1 pts
Top 10
48.2%
Sep 2023 → Jun 2026 · range 47.1% – 63.4%
+1.2 pts
HHI
375
Sep 2023 → Jun 2026 · range 375 – 668
Broadly held−10

Quarterly Activity

vs Mar 31, 2026
New
98
Increased
150
Decreased
116
Sold Out
39
Unchanged
56
Holder count: +59
Institutional value: +72.1%
Shares held: +8.7%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 428
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 886163 CUSIP 53220K504 13F (30d) 275 filings 266 filers Visit website Investor relations